Ignite Creation Date:
2025-12-24 @ 5:30 PM
Ignite Modification Date:
2026-01-24 @ 7:02 AM
Study NCT ID:
NCT01498068
Status:
COMPLETED
Last Update Posted:
2015-01-30
First Post:
2011-12-06
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Open-Label, Bridging Study of Telaprevir in Treatment-Naïve and Treatment-Experienced Russian Patients With Genotype 1 Chronic Hepatitis C
Sponsor:
Janssen-Cilag International NV
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CR100676
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None